Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
20 May 1994Website:
http://www.armatapharma.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 34 min agoDividend
Analysts recommendations
Institutional Ownership
ARMP Latest News
Armata Pharma (ARMP) stock skyrockets 130% in a month due to encouraging progress of the company's pathogen-targeting natural and synthetic phage candidates.
What type of business is Armata Pharmaceuticals?
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
What sector is Armata Pharmaceuticals in?
Armata Pharmaceuticals is in the Healthcare sector
What industry is Armata Pharmaceuticals in?
Armata Pharmaceuticals is in the Biotechnology industry
What country is Armata Pharmaceuticals from?
Armata Pharmaceuticals is headquartered in United States
When did Armata Pharmaceuticals go public?
Armata Pharmaceuticals initial public offering (IPO) was on 20 May 1994
What is Armata Pharmaceuticals website?
https://www.armatapharma.com
Is Armata Pharmaceuticals in the S&P 500?
No, Armata Pharmaceuticals is not included in the S&P 500 index
Is Armata Pharmaceuticals in the NASDAQ 100?
No, Armata Pharmaceuticals is not included in the NASDAQ 100 index
Is Armata Pharmaceuticals in the Dow Jones?
No, Armata Pharmaceuticals is not included in the Dow Jones index
When does Armata Pharmaceuticals report earnings?
The next expected earnings date for Armata Pharmaceuticals is 14 August 2024